O'Shaughnessy C T, Headley P M
Eur J Pharmacol. 1986 Jun 5;125(1):79-83. doi: 10.1016/0014-2999(86)90085-3.
In rat striatal P2 membrane preparations examined under constant experimental conditions, activation of either D2-dopamine or opiate receptors inhibited basal adenylate cyclase with a similar maximal inhibition of approximately 30%. These inhibitions were not additive. D1 dopamine receptor-mediated activation of adenylate cyclase by SKF38393 was inhibited by morphine in an additive fashion, but the opiate had minimal effects on the net activation of adenylate cyclase by dopamine which activates both D1 and D2 receptors. From these results it would appear that opiate and D1 dopamine receptor-mediated activation of adenylate cyclase summate, but that opiate and D2 dopamine receptors regulate a common pool of adenylate cyclase in striatal membranes.
在恒定实验条件下检测的大鼠纹状体P2膜制剂中,D2 - 多巴胺受体或阿片受体的激活均抑制基础腺苷酸环化酶,最大抑制率相似,约为30%。这些抑制作用无相加效应。吗啡以相加方式抑制SKF38393介导的D1多巴胺受体对腺苷酸环化酶的激活,但该阿片类药物对激活D1和D2受体的多巴胺所介导的腺苷酸环化酶净激活作用影响极小。从这些结果看来,阿片受体和D1多巴胺受体介导的腺苷酸环化酶激活作用是相加的,但阿片受体和D2多巴胺受体调节纹状体膜中腺苷酸环化酶的共同池。